Guiming Chen
Impact in
-
- Sirtuins and Resveratrol in Medicine
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 2
- RNA modifications and cancer 2
-
- Cardiac Ischemia and Reperfusion 2
- Co-authors
- Zhanguo Liu (4 shared papers)Haihua Luo (5 shared papers)Yong Jiang (5 shared papers)Shenhai Gong (2 shared papers)Chenyang Huang (2 shared papers)Hongwei Zhou (2 shared papers)Peng Chen (2 shared papers)Ping Chang (3 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Hepatology (1 paper)PeerJ (1 paper)Burns & Trauma (1 paper)JCI Insight (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Guiming Chen
27 papers receiving 428 citations
Peers
Comparison fields: 5 of 66
- Geriatrics and Gerontology 17
- Cancer Research 54
- Molecular Biology 189
- Pharmacology 21
- Immunology 46
Countries citing papers authored by Guiming Chen
This map shows the geographic impact of Guiming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiming Chen more than expected).
Fields of papers citing papers by Guiming Chen
This network shows the impact of papers produced by Guiming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiming Chen. The network helps show where Guiming Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiming Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 126 | |
| 2 | 2016 | 67 | |
| 3 | 2020 | 41 | |
| 4 | 2014 | 36 | |
| 5 | 2018 | 17 | |
| 6 | 2017 | 16 | |
| 7 | 2016 | 16 | |
| 8 | 2017 | 16 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 14 | |
| 11 | 2023 | 10 | |
| 12 | 2022 | 8 | |
| 13 | 2017 | 7 | |
| 14 | 2020 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2014 | 5 | |
| 17 | High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy. | 2021 | 5 |
| 18 | 2021 | 4 | |
| 19 | 2015 | 2 | |
| 20 | THE EXTRACTING CONDITION OF MELANIN FROM THE BANANA SKIN | 2009 | 2 |
About Guiming Chen
Guiming Chen is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 28 papers that have together received 431 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (2 papers), Immune cells in cancer (2 papers), Cardiac Ischemia and Reperfusion (2 papers), Autophagy in Disease and Therapy (2 papers), Neonatal Respiratory Health Research (2 papers), RNA modifications and cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Geriatrics and Gerontology (17 citations), Cancer Research (54 citations), Molecular Biology (189 citations), Pharmacology (21 citations) and Immunology (46 citations). Guiming Chen has collaborated with scholars based in China and United States. Frequent co-authors include Zhanguo Liu, Haihua Luo, Yong Jiang, Shenhai Gong, Chenyang Huang, Hongwei Zhou, Peng Chen, Ping Chang, Lei Li and Mengwei Niu. Their work appears in journals such as Journal of Clinical Oncology, Hepatology, PeerJ, Burns & Trauma and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.